NEWS
Oct 02, 2026

Healthgevity Introduces hydraCELL+™, Featuring Formulation IP Developed by the Seeds Foundation for Cellular Research

BREAKING NEWS

INTERLAKEN, N.J., [October 2, 2026] — Healthgevity, a practitioner-focused precision longevity nutrition company, announced the launch of hydraCELL+™, a cellular hydration and muscle-support formula built on proprietary formulation IP developed through the Seeds Foundation for Cellular Research and licensed to Healthgevity.

The formula reflects the cellular medicine approach advanced by William Seeds, MD, and the Seeds Scientific Research & Performance Institute, bringing that foundation into a practical nutritional option for practitioners working in healthspan, weight management and performance care.

Muscle plays a central role in healthy aging, supporting mobility, metabolic health and physical resilience. Maintaining muscle strength and function is an important consideration during aging, caloric restriction and demanding training. hydraCELL+™ was developed to support muscle physiology through complementary approaches to cellular hydration, nutrient signaling and energy availability.*

Each serving combines 8 g of Pürest Creatine™ (creatine monohydrate), 10 g of trehalose, 5 g of L-alanine, 4 g of glycine, 3 g of L-glutamine and 3 g of L-leucine. The formula is organized around three complementary actions:

  • Volumize: Creatine supports intracellular hydration and healthy muscle cell volume.*
  • Signal: Leucine supports nutrient signaling involved in muscle protein synthesis.*
  • Perform: Creatine supports phosphocreatine availability and ATP regeneration for exercise performance.*

“Maintaining muscle is a priority across weight management, healthy aging and performance care,” said Michael Antonelli, Founder and CEO of Healthgevity. “hydraCELL+ brings the cellular medicine approach advanced by Dr. Seeds into a practical, research-informed formula that combines creatine and targeted amino acids to support cellular hydration, muscle signaling and performance.”

hydraCELL+™ is designed to complement adequate dietary protein, resistance exercise and individualized practitioner-directed care. Its ingredient foundation includes creatine monohydrate, an extensively studied nutritional ingredient for muscle strength and exercise performance. Ingredient research informs the formulation; it does not establish clinical outcomes for the finished product.

hydraCELL+™ is available now through Healthgevity practitioner wholesale accounts, with direct-to-patient ordering and fulfillment available through the Healthgevity HCP affiliate program.

For product details and directions, visit healthgev.com/products/hydracell.

Healthgevity is a Trusted Partner of SSRP, reflecting a shared commitment to supporting practitioners with science-informed tools, education and resources aligned with the evolving field of cellular medicine. Through the Trusted Partner Network, SSRP works with organizations that demonstrate a commitment to quality, scientific integrity and meaningful support of the SSRP provider community.

For more information and to view the Healthgevity Partner Page, visit:
SSRP Healthgevity Partner Page

About Healthgevity 

Healthgevity® develops practitioner-exclusive formulations built on Precision Signaling Nutrition™, combining bioactive peptides, biofunctional proteins and clinically informed nutraceuticals. Working alongside physicians, researchers and biotechnology innovators, Healthgevity develops nutritional tools for healthy aging, metabolic health, gut health and performance.


*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

RELATED RESOURCES

Continue exploring related topics.

VIEW ALL
VIDEO
Cellular Medicine Mondays
Sep 28, 2026
Ep. 107 - Anti-Ageing Mini Mastermind Part 1
Preview only
Journal Club – Episode 107

Mini Anti-Aging Mastermind Part 1: Restored clearance of senescent neutrophils by tissue-resident macrophages limits organ aging

Part 1 of a special Mini Anti-Aging Mastermind inspired by the recent Science article exploring how impaired clearance of senescent neutrophils may contribute to age-related organ decline. Dr. Seeds begins breaking down the cellular mechanisms behind the research and what they reveal about the biology of aging. (Article Link)

Preview Only — Become a member for full access
ARTICLE
William Seeds, MD
Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
William Seeds, MD Sep 23, 2026
The Future of Regenerative Medicine May Begin with a Hair Follicle
Why a Plucked Hair Follicle May Matter to the Future of Regenerative Medicine In this article, I return to a study that I discussed in a July Journal Club post. The study, published in Cells in 2024, investigated whether cells obtained from plucked, cryopreserved human hair follicles could be reprogrammed into induced pluripotent stem cells […]
READ ARTICLE
Peptide Therapy Certification 2026
The SSRP Peptide Therapy Certification course gives clinicians, researchers, and other healthcare providers a working method for applying Cellular Medicine principles to patient care through clinical peptide therapy. Across 19 faculty-led lessons, Dr. William Seeds and SSRP faculty, including Siobhan...
19 Lessons
15 hrs 43 min
View Course
VIDEO
Cellular Medicine Mondays
Sep 21, 2026
Ep. 106 - Peptide Support After Transplant: What to Consider First
Preview only
Dissecting Protocols – Episode 106

Peptide Support After Transplant: What to Consider First

Dr. Seeds explores how to protect graft integrity and identify the right cellular targets before considering peptide support in a patient six years post liver transplant.

Preview Only — Become a member for full access
SSRP Institute Sep 14, 2026
In Case You Missed it: FDA Approves Mounjaro (tirzepatide) for CVD
HEADLINE SCIENCE [Sept 14, 2026] – On August 28, 2026, the FDA expanded the indication for Mounjaro (tirzepatide), approving the dual GIP/GLP-1 receptor agonist to reduce the risk of major adverse cardiovascular events—including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke—in adults with type 2 diabetes at high cardiovascular risk. The decision makes tirzepatide the […]
READ NEWS
EVENT
Certification
September 10 - 11, 2027
Peptide Therapy Certification 2027
Four Seasons Resort Orlando at Walt Disney World, FL
COMING SOON
Certification
Peptide Therapy Certification 2027
COMING SOON
EVENT
World Congress
June 17 - 19, 2027
Peptide World Congress 2027
Arizona Biltmore, Phoenix, AZ
COMING SOON
World Congress
Peptide World Congress 2027
COMING SOON
EVENT
Mastermind
February 15 - 19, 2027
Fellowship Mastermind Summit 2027
Gansevoort Meatpacking NYC, New York, NY
COMING SOON
Mastermind
Fellowship Mastermind Summit 2027
COMING SOON
EVENT
Grand Rounds
December 4 - 5, 2026
Grand Rounds
Four Seasons Resort and Residences Vail
COMING SOON
Grand Rounds
Grand Rounds
COMING SOON
VIDEO
Cellular Medicine Mondays
Sep 14, 2026
Ep. 105 - Dr. Seeds’ Office Hours
Preview only

Subscribe to the SSRP Community Digest

Get the latest research and developments in the field of Cellular Medicine straight to your inbox every month.

This field is for validation purposes and should be left unchanged.